Antibody Therapeutics, 2021
Full text: Unavailable
Abstract In this review, we have summarized the current landscape of therapeutic antibody optimization for successful development. By engineering antibodies with display technology, computer-aided design and site mutagenesis, various properties of the therapeutic antibody candidates can be improved with the purpose of enhancing their safety, efficacy and developability. These properties include antigen binding affinity and specificity, biological efficacy, pharmacokinetics and pharmacodynamics, immunogenicity, and physico-chemical developability features. A best-in-class strategy may require the optimization of all these properties to generate a good therapeutic antibody.